THE IMPACT OF THE NEW CLASSIFICATION OF IDIOPATHIC INTERSTITIAL PNEUMONIAS ON CLINICAL PRACTICE
Keywords:
interstitial lung diseases, classification, criteriaAbstract
Background. New pathologic classification of interstitial pulmonary diseases of unknown etiology from 1998 enables better clinical approach to these diseases already in their early stages. As a result, key parameters for treatment choice and prognosis are easier to summarise.
Conclusions. The article presents the basis for new pathologic classification and its role in clinical practice. In addition, the lastest international multidisciplinary consensus of pathological/clinical classification of ihese diseases, having been edited by American Thoracic Society and European Thoracic Society in June 2001, is presented. Every individual entity is illustrated with corresponding histologic pattern of our recently hospitalised typical cases. Finaly, some new therapeutic approaches are introducted which are oriented to actual immunopathogenetic stage of interstitial pulmonary disease.
Downloads
References
Liebow AA, Carrington CB. The interstitial pneumonias. In: Simon M, Potchen EJ, LeMay M eds. Frontiers of pulmonary radiology. New York: Grune and Stratton, 1969: 102–41.
Katzenstein ALA, Myers JL. Idiopathic pulmonary fibrosis. Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998; 157: 1301– 15.
Costabel U. Die neue Klassifikation der idiopathischen interstitiellen Pneumonien. Pneumologie 2000; 54: 447–53.
American Thoracic Society / European Respiratory Society. International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277–304.
King TE, Costabel U, Cordier JF, doPico GA, du Bois RM, Lynch D et al. Idiopathic pulmonary fibrosis: Diagnosis and treatment. Am J Crit Care Med 2000; 161: 646–64.
Nagai S, Kitaichi M, Itoh H, Nishimura K, Izumi T, Colby TV. Idiopathic nonspecific interstitial pneumonia/fibrosis: comparisson with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998; 12: 1010–9.
Katzenstein ALA, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994; 18: 136– 47.
Flacherty KV, Travis WD, Toews GB, Kazerooni EA, Gross BH, Jain A et al. Histopathologic variability in usual and nonspecific interstitial pneumonias. Am J Crit Care Med 2001; 164: 1722–7.
Lohr RH, Boland BJ, Douglas WW, Dekrell DH, Colby TV, Swensen SJ et al. Organizing pneumonia, features and prognosis of cryptogenic, secondary, and focal variants. Arch Intern Med 1997; 157: 1323–9.
Yousem SA, Colby TV, Gaensler EA. Respiratory bronchiolitis-associated interstitial lung disease and its relationship to desquamative interstitial pneumonia. Mayo Clin Proc 1989; 64: 1373–80.
Du Bois RM, Wells AU. Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis. Eur Respir J 2001; 18: Suppl 32: 43s–55s.
Mušič E, Osolnik K. New clinical approaches to interstitial lung diseases. Zbornik prispevkov. 2. Slovenski pnevmološki in alergološki kongres z mednarodno udeležbo. Portorož, 16.–18. november 2000. Golnik: Združenje pnevmologov, 2000: 43–8.
Downloads
Issue
Section
License
The Author transfers to the Publisher (Slovenian Medical Association) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Slovenian Medical Association) has the right to transfer the rights of acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.
